About

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut, where he also earned his M.D. from the Faculty of Medicine in 1996. He further obtained an M.P.H. from the Johns Hopkins University School of Public Health. His medical training includes a residency in internal medicine at MedStar Health, completed in 1998, and a residency in dermatology at Johns Hopkins University School of Medicine, completed in 2002. He is board-certified in dermatology by the American Board of Dermatology since 2002. Dr. Alhariri's professional background emphasizes his extensive training and expertise in dermatology, with a focus on providing high-quality patient care.

Research topics

• Dermatology
• Surgery
• Internal medicine
• Medicine
• Gastroenterology
• Pathology
• Endocrinology

Selected publications

• Reply to Akhter et al., "Evolving performance of GPT models in dermoscopic diagnosis: Comment on 'Comparative assessment of GPT-4 Vision in dermoscopic image analysis'"

  Journal of the American Academy of Dermatology · 2026-05-01

  articleSenior author
  PublisherDOI

• Comparative assessment of GPT-4 vision in dermoscopic image analysis

  Journal of the American Academy of Dermatology · 2025-08-21 · 2 citations

  articleSenior author
  PublisherDOI

• Response to Ke et al., “Methodological considerations of GPT-4 vision in dermoscopic image analysis”

  Journal of the American Academy of Dermatology · 2025-12-08

  letterSenior author
  PublisherDOI

• 54557 Assessing artificial intelligence chatbots’ ability to generate differential diagnoses for dermatologic conditions

  Journal of the American Academy of Dermatology · 2024-09-01

  articleSenior author
  PublisherDOI

• Demographics, Cutaneous Manifestations, and Comorbidities Associated with Progressive Cutaneous Sarcoidosis: A Retrospective Cohort Study

  Medicines · 2023-10-12

  articleOpen access

  Background: Sarcoidosis is a multisystem granulomatous disease with a wide variety of presentations and clinical courses. Cutaneous manifestations and comorbidities associated with sarcoid prognosis remain understudied. Methods: An EPIC query was run for patients age 18+ at the Johns Hopkins Hospital with a diagnosis of sarcoidosis of the skin according to the ICD-10-CM code D86.3. Data were obtained from a population-based sample of 240 patients from 2015 to 2020. Results: A total of 240 patients were included in the cohort study. The mean (SD) age was 43.76 (11.72) years, and 30% of participants were male; 76.25% of patients identified as black, 19.58% as white, and 4.17% as other. The average age of onset in remissive patients was significantly higher than progressive (47 ± 12 vs. 40 ± 10, p = 0.0005); 49% of black patients experienced progressive sarcoid compared to 32.6% of white patients (p = 0.028). Progressive disease was associated with the presence of lupus pernio (aOR = 3.29, 95% CI, 1.60–6.77) and at least one autoimmune comorbidity (aOR 6.831, 95% CI 1.819–11.843). Conclusions: When controlling for patient demographics, lupus pernio and the presence of at least one autoimmune condition were associated with progressive cutaneous sarcoidosis.

  PublisherOA PDFDOI

• 253 Racial differences in cutaneous sarcoidosis

  Journal of Investigative Dermatology · 2021-04-19

  article
  PublisherDOI

• 468 Clinical characteristics, etiology, and treatment of erythema multiforme at a tertiary care center

  Journal of Investigative Dermatology · 2020 · 1 citations

  • Medicine
  • Internal medicine
  • Dermatology
  PublisherDOI

• 427 Leukocytoclastic vasculitis with and without IgA deposition is associated with renal damage: A case-control study

  Journal of Investigative Dermatology · 2020-06-16

  article
  PublisherDOI

• Comorbidities Associated with Granuloma Annulare: A Cross-Sectional, Case-Control Study

  Medicines · 2020 · 9 citations

  • Medicine
  • Internal medicine
  • Dermatology

  Our results support the reported association between GA and type II diabetes. Furthermore, our findings indicate that GA may be associated with cigarette smoking and non-migraine headache disorders.

  PublisherOA PDFDOI

• 494 Association of granuloma annulare with type II diabetes, cigarette smoking, and liver disease: A case-control study

  Journal of Investigative Dermatology · 2020-06-16 · 1 citations

  article
  PublisherDOI

Frequent coauthors

• Shawn G. Kwatra

  University of Maryland, Baltimore

  23 shared

• Justin Choi

  Johns Hopkins University

  12 shared

• Yevgeniy R. Semenov

  Massachusetts General Hospital

  8 shared

• Erik Almazan

  8 shared

• Kirsten M. Williams

  Emory University

  6 shared

• Nishadh Sutaria

  Johns Hopkins University

  6 shared

• Kyle A. Williams

  Harvard University

  6 shared

• Benjamin H. Kaffenberger

  The Ohio State University Wexner Medical Center

  6 shared

Education

• B.S.

  American University of Beirut

• M.D.

  American University of Beirut

• Other

  Johns Hopkins University School of Public Health